INDEPENDENCE & HEALTH-SPAN
MEET RICHARD
Retired but not ready to slow down
Richard is 67. Retired two years ago and expected it to feel like relief. It did, for a while.
What he didn't expect was how quickly the body would start sending signals he could no longer explain away with work stress. He'd be in a conversation and lose a name he'd known for twenty years. He'd read a page and realize he hadn't retained a word of it. Small, everyday things his wife noticed before he admitted to them.
His right knee had been stiff for years — he'd always attributed it to an old skiing injury and kept moving. But lately, moving hurt more than it used to.
His doctor ran an annual panel: Cholesterol slightly elevated, blood pressure at the high end of normal, blood sugar trending. Nothing that required immediate action, but required attention.
1 in 3
adults over 65 have significant cardiometabolic risk markers that a standard annual physical fails to detect.
He'd watched two close friends — men his age, similarly healthy — have cardiac events in the same calendar year. One recovered fully. One didn't. Richard decided that waiting for a reason to act wasn't a strategy.
"I spent forty years building my business. I didn't expect the second act to feel like I was losing ground."
Performance-Based Biomarker Insights
LIVV ran a comprehensive longevity panel, a full picture of where Richard's biology actually was, not where a standard annual physical suggested it might be.
ApoB and Lp(a): elevated
→ Stronger cardiac predictors than LDL — missed on standard panel
Testosterone: significantly below optimal
→ Adrenal fatigue from sustained output
IGF-1: suboptimal
→ Fatigue, muscle loss, metabolic drift
NAD+ levels: severely depleted
→ Key driver of energy decline and cognitive slowdown
Homocysteine elevated, B12 suboptimal
→ Significant cognitive decline risk — never flagged
The data, alongside a deep review of Richard's lifestyle, health history, and goals with LIVV's physician, provided a clear path forward to stay ahead of drift.
A Personalized & Evolving Health Strategy
LIVV built Richard a protocol focused on the things that mattered most to him: staying sharp, staying mobile, staying independent, and closing the gap between his biological age and the life he intended to keep living.
Peptide Therapy
Epithalon for cellular longevity and Cerebrolysin — a neuroprotective peptide to support cognitive function, BDNF production, and neurological resilience. Directly addressing his memory concerns and the homocysteine-driven cognitive risk his panel revealed.
Hyperbaric Oxygen Therapy
An incredible technology for brain health, cardiovascular support, systemic inflammation reduction, and mitochondrial efficiency. One of the most evidence-backed interventions for the cardiometabolic and cognitive risk profile his panel revealed.
Hormone Optimization
A combination of testosterone to restore his hormonal baseline and drive and CJC / Ipamorelin to stimulate growth hormone for lean muscle, deep sleep, and IG-1 restoration.
VItamin IV s
Targeted micronutrient therapy to address his B12 deficiency, homocysteine elevation, and the specific gaps his panel surfaced that oral supplementation wasn't reaching.
Stem IVs
Systemic regenerative intervention for immune modulation, cellular repair, and anti-aging support at the level his biological age gap warranted.
PRP Joint Injections
His own concentrated growth factors delivered into the joint structure that had been limiting his mobility and golf game, stimulating cartilage repair and reducing the chronic inflammation cortisone had only been masking
Richard’s medical team maintained weekly touchpoints to ensure consistency and momentum, while quarterly labs allowed his protocol to be continuously refined, adapting in real time to support the results he was working toward.
Overtime, LIVV became part of his lifestyle. He lived close by and started everyday with a sauna session. Quarterly social events expanded his network and he met a community of like-minded people his age who were staying ahead of their health.
THE SHIFT: 30 DAYS IN
Sleep was the first shift — deeper, more restorative, waking up with an energy that felt different from caffeine.
The knee stiffness that had become his morning baseline had meaningfully reduced. He was taking the stairs without thinking about it — which he only noticed because he realized he'd stopped avoiding them.
His wife mentioned that he seemed more present in conversations. He'd noticed it too — less searching, faster retrieval, more like the version of himself that used to hold a boardroom.
"I had so much more control than I realized."
THE SHIFT: 6 MONTHS IN
ApoB and Lp(a) improved, his cardiologist asked what changed.
His DEXA scan showed lean muscle mass trending upward for the first time in years. His knee? zero cortisone in six months. He played 18 holes last Saturday without thinking about it.
Cognitively, he had a sharpness he hadn't expected to recover. He was even writing again, a memoir project he'd abandoned because he couldn't hold the thread.
He wasn't the same man he was at 50. He didn't need to be. But he was a version of 67 that felt like a choice, not a sentence.
"My peers were managing decline. LIVV gave me a different option... not to pretend aging isn't happening, but to change how it happens. That's everything."
COMPANY
OUR LOCATION
LIVV Little Italy 800 West Ivy St, Suite A San Diego CA 92101
CUSTOMER CARE
CONTACT US: (619) 840-6700
SUPPORT: LIVV@LIVVNATURAL.COM
COMPANY
LOCATION
LEGAL
FOLLOW US
To protect member privacy, the journeys depicted on this page are illustrative composites inspired by real member experiences — not individual case studies. Names, identifying details, and specific circumstances are fictional. Individual results depend on individual health status, protocol adherence, and other factors, and are not guaranteed.
These statements have not been evaluated by the Food and Drug Administration. Services and therapies described are not intended to diagnose, treat, cure, or prevent any disease.
Copyright LIVV Naturopathic Inc 2026. All Rights Reserved.